Article

Circulating plasma cells (either polyclonal or monoclonal) as markers of aggressive Multiple Myeloma phenotype

2025-11-07

Abstract excerpt

<title>Abstract</title> <p> Multiple myeloma (MM) is a hematological neoplasm characterized by the clonal proliferation of malignant plasma cells (PCs) in the bone marrow (BM). The pathogenesis of MM is complex and multifactorial, with significant heterogeneity among patients, making risk stratification and disease monitoring difficult, often based on invasive sampling. Therefore, there is growing interest in le...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5b053070-b939-5192-b3dc-c8f299eb9560
DOI: 10.21203/rs.3.rs-7874753/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating plasma cells (either polyclonal or monoclonal) as markers of aggressive Multiple Myeloma phenotypeDOI 10.21203/rs.3.rs-7874753/v1Read

Clinical significance and molecular characteristics of circulating plasma cells in multiple myelomaSemantic proximity Read

Genotypic identification of polyclonal plasma cells in plasma cell dyscrasias shows an aberrant single-cell phenotype with clinical implicationsSemantic proximity Read

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.Semantic proximity Read

Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice.Semantic proximity Read

Plasma cell myeloma with RAS/BRAF mutations: Clinicopathologic, molecular genetic features and outcomes of 68 patientsSemantic proximity Read

Multiple Myeloma and Precursor Plasma Cell Disorders: From Emerging Driver Mutations to Current and Future Therapeutic StrategiesSemantic proximity Read

Multiple Myeloma: Heterogeneous in Every WaySemantic proximity Read

Plasma Cell Enrichment and New Genomic Approaches in Multiple Myeloma: A Scoping ReviewSemantic proximity Read

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myelomaSemantic proximity Read

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read

Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma.Semantic proximity Read

Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential.Semantic proximity Read